(Q48347863)

English

A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.

scientific article published on 14 September 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Leen Van Brussel

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Stasia Borowski

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Monica Escalada

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sean P Mahabir

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Rodney R Walters

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michael R Stegemann

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

14 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Veterinary Dermatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

593-e145

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Further validation of a pruritus severity scale for use in dogs

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Antibody therapy of cancer

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

A longitudinal study on diarrhoea and vomiting in young dogs of four large breeds

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

The skin microbiome in allergen-induced canine atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12478

21 January 2018

Identifiers

10.1111/VDE.12478

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28906040%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48347863&oldid=1578247078"